Does anti-VEGF bevacizumab improve survival in experimental sepsis?
Emmanuel Besnier1,2, Ebba Brakenhielm3, Vincent Richard3
1Normandie Univ, UNIROUEN, INSERM U1096, 76000, Rouen, France. emmanuel.besnier@chu-rouen.fr.
Critical Care (London, England)
|July 6, 2017
Abstract
No abstract available in PubMed .


